Completed Cells, Biochemistry & Physiology Chemistry

Structural Biology in the RFI

In plain English

AI plain-English summary

A consortium of ten UK universities, central facilities, and industry partners is building new tools to see the inner workings of biological molecules in unprecedented detail. The problem is that current methods for imaging proteins and other biomolecules are too slow, too static, or too limited in scale. Many of the molecules most relevant to drug discovery and biotechnology—large, transient assemblies or unstructured proteins—remain invisible to existing techniques. This gap blocks progress in designing new pharmaceuticals, industrial enzymes, and agricultural chemicals. If the research succeeds, it will transform how drugs are discovered. Fragment-based drug discovery pipelines will become faster and more reliable. New hardware for electron microscopes and tomographs will capture molecules in motion, not just static snapshots. Combining imaging data from different sources will reveal how proteins change shape over time—the fourth dimension of structural biology. The project is applied, not fundamental curiosity-driven research. Its explicit goal is to deliver practical breakthroughs for the life sciences sector, from pharmaceutical development to industrial biotechnology. The payoff is a new generation of imaging infrastructure that lets researchers see what has been invisible, and use that sight to engineer better medicines and materials.

View original technical description
The RFI is a UK government funded initiative that will bring together Academia and Industry to solve the most pressing problems in the life sciences (Industrial Biotechnology, Pharmaceutical, Agrichemical). It has a Hub at Harwell and currently ten University partners (Spokes). Its goal is to deliver innovative new physical science that will transform the life sciences. The RFI has five interlinked scientific themes; structural biology, next generation chemistry, imaging with sound and light, mass spectrometry and next generation electron microscopy. Four broad areas of structural biology are identified where breakthroughs in the underlying methodology would be transformative. These are the extension to larger transient assemblies, the transformation of structure-guided drug discovery, reaching into the fourth (time) dimension and tackling unstructured proteins. In order to deliver impact in these areas, the RFI will undertake research in new approaches to manipulating cells and macromolecules, sample preparation; novel sample delivery particularly to electron microscopes / tomographs; new hardware for imaging; correlating imaging data from different sources; in developing a new pipelines for fragment-based drug discovery; and in combining imaging modalities to reach into the time domain. To realise these goals RFI requires a unique partnership between 10 Universities, the UK's central Facilities and most importantly UK Industry.

View the original record at the funder ↗

Researchers

James Naismith (Principal Investigator)Ray Owens (Co-Investigator)

Related Research

Grants with similar aims, by meaning.

Rosalind Franklin Institute : Establishment Phase
A High-throughput discovery facility for the Rosalind Franklin Institute
Construction of the Rosalind Franklin Institute Hub
Recurrent funding for the RFI 2019 to 2021
Capital funding for NMR

Original classification

Research Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.